Respiratory failure in Pompe disease: Treatment with noninvasive ventilation
Abstract
In this study, noninvasive ventilation (NIV) was prospectively applied to eight patients (35.8 ± 11.4 years) with late-onset Pompe disease and respiratory failure apparent from severe restrictive lung disease, nocturnal hypoxemia (83 ± 8%), and daytime hypercapnia (66.7 ± 17.9 mm Hg). The impact of NIV on respiratory function was followed for 34 ± 17 months. Despite further decrease of vital capacity and inspiratory muscle strength, NIV normalized oxygen saturation during sleep (96 ± 1%), daytime carbon dioxide tensions (44.1 ± 3.6 mm Hg), and symptoms.
Get full access to this article
View all available purchase options and get full access to this article.
References
1.
Ausems MG, Verbiest J, Hermans MP, et al. Frequency of glycogen storage disease type II in the Netherlands: implications for diagnosis and genetic counselling. Eur J Hum Genet 1999;7:713–716.
2.
Kuo WL, Hirschhorn R, Huie ML, Hirschhorn K. Localization and ordering of acid alpha-glucosidase (GAA) and thymidine kinase (TK1) by fluorescence in situ hybridization. Hum Genet 1996;97:404–406.
3.
Engel AG, Hirschhorn R. Acid maltase deficiency. In: Engel AG, Franzine-Armstrong C, eds. Myology: basic and clinical. New York: McGraw-Hill, 1996:1533–1553.
4.
Mellies U, Ragette R, Schwake C, Baethmann M, Voit T, Teschler H. Sleep-disordered breathing and respiratory failure in acid maltase deficiency. Neurology 2001;57:1290–1295.
5.
Mier-Jedrzejowicz A, Brophy C, Moxham J, Green M. Assessment of diaphragm weakness. Am Rev Respir Dis 1988;137:877–883.
6.
Mellies U, Ragette R, Schwake C, Boehm H, Voit T, Teschler H. Daytime predictors of sleep disordered breathing in children and adolescents with neuromuscular disorders. Neuromusc Disord 2003;13:123–128.
7.
Keunen RW, Lambregts PC, Op de Coul AA, Joosten EM. Respiratory failure as initial symptom of acid maltase deficiency. J Neurol Neurosurg Psychiatry 1984;47:549–552.
8.
Mellies U, Ragette R, Dohna Schwake C, Boehm H, Voit T, Teschler H. Long-term noninvasive ventilation in children and adolescents with neuromuscular disorders. Eur Respir J 2003;22:631–636.
9.
Van den Hout HJ, Reuser AJ, Vulto AG, Loonen MC, Cromme-Dijkhuis A, Van der Ploeg AT. Recombinant human alpha-glucosidase from rabbit milk in Pompe patients. Lancet 2000;356:397–398.
10.
Winkel LP, Kamphoven JH, van den Hout HJ, et al. Morphological changes in muscle tissue of patients with infantile Pompe’s disease receiving enzyme replacement therapy. Muscle Nerve 2003;27:743–751.
Information & Authors
Information
Published In
Copyright
© 2005.
Publication History
Published online: April 25, 2005
Published in print: April 26, 2005
Authors
Metrics & Citations
Metrics
Citation information is sourced from Crossref Cited-by service.
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Pharmacological modulation of respiratory control: Ampakines as a therapeutic strategy, Pharmacology & Therapeutics, 265, (108744), (2025).https://doi.org/10.1016/j.pharmthera.2024.108744
- Risk of Cardiac Arrhythmias in Patients with Late-Onset Pompe Disease—Results from a Long Follow-Up in a Group of 12 Patients and Review of Literature, Cardiogenetics, 14, 1, (38-50), (2024).https://doi.org/10.3390/cardiogenetics14010003
- The European reference network for metabolic diseases (MetabERN) clinical pathway recommendations for Pompe disease (acid maltase deficiency, glycogen storage disease type II), Orphanet Journal of Rare Diseases, 19, 1, (2024).https://doi.org/10.1186/s13023-024-03373-w
- A Rare Case of Late Onset-Pompe’s Disease: Presented as Heart Failure, American Journal of Pediatrics, 10, 3, (132-135), (2024).https://doi.org/10.11648/j.ajp.20241003.15
- Evaluating avalglucosidase alfa for the management of late-onset Pompe disease, Expert Review of Neurotherapeutics, 24, 3, (259-266), (2024).https://doi.org/10.1080/14737175.2024.2306855
- S3-Leitlinie: Nichtinvasive Beatmung als Therapie der chronischen respiratorischen Insuffizienz, Pneumologie, (2024).https://doi.org/10.1055/a-2347-6539
- An expert rule-based approach for identifying infantile-onset Pompe disease patients using retrospective electronic health records, Scientific Reports, 14, 1, (2024).https://doi.org/10.1038/s41598-024-72259-5
- Gene Therapy Developments for Pompe Disease, Biomedicines, 10, 2, (302), (2022).https://doi.org/10.3390/biomedicines10020302
- A Systematic Review investigating the Effectiveness of Exercise training in Glycogen Storage Diseases, Therapeutic Advances in Rare Disease, 3, (2022).https://doi.org/10.1177/26330040221076497
- Manifestations pulmonaires des maladies héréditaires du métabolisme, Revue des Maladies Respiratoires, 39, 9, (758-777), (2022).https://doi.org/10.1016/j.rmr.2022.09.002
- See more
Loading...
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.